Quaker Chemical Corporation (KWR) presents a deeply negative liquidation recovery posture as of March 31, 2026, consistent with prior periods. Total assets of $2.80B are dominated by intangible assets that carry zero recovery value under a liquidation lens: goodwill of $502M (net of $190M accumulated impairment) and finite-lived intangibles of $650M plus indefinite-lived intangibles of $198M, together representing approximately $1.35B of zero-recovery assets. PP&E net of $311M recovers at 50-70%, yielding roughly $156-218M. Cash of $170M recovers at par, though $163M is held in foreign subsidiaries and may face repatriation friction. AR of $441M at 90-95% recovery yields approximately $397-419M. Inventory of $282M (finished goods/WIP $154M plus raw materials $129M) at 60% yields approximately $169M. Applying standard liquidation haircuts to the tangible asset stack and assigning zero to all intangibles and goodwill produces a gross recoverable asset value in the range of approximately $950M-$1.05B against total liabilities of $1.42B at face value, generating a significant shortfall before any equity recovery. This is consistent with MFFAIS CLV of -$1.08B and LLV of -$637M. The liability stack at March 31, 2026 includes total debt of $875M (Revolver $243M at 4.85%, U.S. Term Loan $475M at 5.02%, Euro Term Loan $143M at 3.25%, industrial development bonds $10M), pension obligations of $22M non-current plus $2M current, deferred tax liabilities of $132M, and operating lease liabilities of $35M. All remain at face value in liquidation. The credit facility matured in June 2027 under the existing structure; however, a subsequent event disclosed in April 2026 refinanced the entire facility into a new $800M revolver, $550M U.S. term loan, and $250M Euro equivalent term loan maturing April 2031, eliminating near-term maturity risk from a going-concern perspective but not changing the liquidation picture. Interest rate swap hedges providing fixed-rate protection on $300M notional expired in March 2026 and were replaced post-quarter with $400M notional four-year swaps at 3.58% plus margin, leaving the March 31 balance sheet briefly exposed to full variable rate. Two active restructuring programs (2022 and 2026) are generating ongoing cash outflows and balance sheet restructuring reserves of $9.5M. The filing discloses a 2026 global business transformation program expected to run through 2028 with one-time cash costs estimated at 1.0-1.5x annualized savings target of $20-30M; total contingent restructuring cash liability of up to ~$45M is discussed in MD&A but not separately XBRL-tagged as a committed obligation. Filing does not separately tag the defined benefit pension obligation funded status or unfunded PBO in XBRL for this period; only the balance sheet carrying values of pension liabilities ($22M total) are tagged.
▼ Community Notes